Robot-Assisted Lymph Node-to-Vein Anastomosis: Lessons from the First 22 Cases at a High-Volume Lymphatic Supermicrosurgery Center
Current Oncology · 29.06.2025 · 32 (7) · 377
DOI: 10.3390/curroncol32070377 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, online erschienen am 29.06.2025. Verfasst von Wei F Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Lymphedema Research and Reconstruction, Department of Plastic Surgery, Cleveland Clinic, Cleveland, OH 44124, USA. Hauptthemen laut MEDLINE: Robotic Surgical Procedures, Anastomosis, Surgical, Microsurgery, Lymph Nodes. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
(1)
Background
Lymphedema is a common but underrecognized sequela of cancer treatment. Supermicrosurgical procedures such as lymphaticovenular anastomosis (LVA) and, more recently, lymph node-to-vein anastomosis (LNVA) have emerged as effective options for fluid-predominant disease. In 2024, we began performing robot-assisted LNVA using a next-generation microsurgical robot. This study describes our initial experience, technical insights, and the potential for robotics to extend the boundaries of supermicrosurgery. (2)
Methods
Twenty-two consecutive robotic LNVAs were performed by a high-volume supermicrosurgeon at a tertiary center. Preoperative imaging with standard and ultra-high frequency ultrasound was used to identify optimal lymph nodes and veins. Robotic LNVA was performed using the Symani Surgical System, with adaptations for motion scaling, ergonomics, and console control. Intraoperative patency was confirmed by direct washout and/or indocyanine green (ICG) transit. (3)
Results
All 22 procedures were technically successful, with 100% intraoperative patency. Anastomosis time improved from 37 to 18 min. Robotic assistance enhanced precision, eliminated tremors, and reduced the technical burden of operating at extreme submillimeter scales. (4)
Conclusions
Robotic LNVA is safe, feasible, and efficient. It optimizes current techniques, offering the potential to extend surgical access below the 0.1 mm threshold, with implications for future treatment of lymphatic and possibly intracranial disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Lymphedema Research and Reconstruction, Department of Plastic Surgery, Cleveland Clinic, Cleveland, OH 44124, USA.
- Division of Reconstructive Microsurgery, Department of Plastic and Reconstructive Surgery, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan 333, Taiwan.
ORCID-Profile: David C F Cheong, Melis Salman
Zitieren
APA
Chen, W. F., Cheong, D. C. F., Tedone Clemente, E., & Salman, M. (2025). Robot-Assisted Lymph Node-to-Vein Anastomosis: Lessons from the First 22 Cases at a High-Volume Lymphatic Supermicrosurgery Center. Current Oncology, 32(7), 377. https://doi.org/10.3390/curroncol32070377
Vancouver
Chen WF, Cheong DCF, Tedone Clemente E, Salman M. Robot-Assisted Lymph Node-to-Vein Anastomosis: Lessons from the First 22 Cases at a High-Volume Lymphatic Supermicrosurgery Center. Current Oncology. 2025;32(7):377. doi:10.3390/curroncol32070377
BibTeX
@article{Chen2025,
author = {Chen, Wei F and Cheong, David C F and Tedone Clemente, Erica and Salman, Melis},
title = {Robot-Assisted Lymph Node-to-Vein Anastomosis: Lessons from the First 22 Cases at a High-Volume Lymphatic Supermicrosurgery Center},
journal = {Current Oncology},
year = {2025},
volume = {32},
number = {7},
pages = {377},
doi = {10.3390/curroncol32070377}
}
EUVIMED